ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,518Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 1448

$322K Total Retail Price of All Prescriptions

Rank: 305 out of 1448

856 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 856 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 8,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL TARTRATE 1,204 974 1 9
ISOSORBIDE DINITRATE 1,010 867 10 2 63
SIMVASTATIN 685 576 3 3
ENALAPRIL MALEATE 627 520 4 48
HYDROCHLOROTHIAZIDE 616 498 5 18
CARVEDILOL 380 321 6 1
FUROSEMIDE 281 259 7 7
LOSARTAN POTASSIUM 250 234 8 11
CLONIDINE HCL 221 188 9 45
AMLODIPINE BESYLATE 217 184 10 2
LISINOPRIL 197 149 11 5
DIOVAN 187 143 12 15
POTASSIUM CHLORIDE 179 147 13 19
ISOSORBIDE MONONITRATE ER 158 130 14 16
ATENOLOL 138 126 15 12
RANEXA 134 133 16 37
BENAZEPRIL HCL 132 93 17 26
METOLAZONE 124 106 18 124
QVAR 120 89 19 270
CLOPIDOGREL 119 103 20 10
LEVOTHYROXINE SODIUM 116 104 21 21
PLAVIX 97 92 22 14
OMEPRAZOLE 96 94 23 23
DILTIAZEM HCL 87 79 24 145
METFORMIN HCL 84 77 25 25
KLOR-CON 10 82 73 26 102
DIGOXIN 66 59 27 13
NITROSTAT 64 54 28 31
GLYBURIDE 63 63 R 29 89
KLOR-CON 8 59 51 30 70
DIOVAN HCT 54 48 31 29
CRESTOR 50 34 32 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.